市场调查报告书
商品编码
1413879
生物製造中的病毒检测和定量市场:按产品类型、技术、应用和最终用户划分 - 2024-2030 年全球预测Biomanufacturing Viral Detection & Quantification Market by Offering Type (Consumables, Instruments, Services), Technology (Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Plaque Assay), Application, End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
生物製造领域的病毒检测和定量市场规模预计到2023年为26.7亿美元,2024年达到28.9亿美元,2030年达到47.1亿美元,复合年增长率为8.40%。
生物製造中病毒检测和定量的全球市场
主要市场统计 | |
---|---|
基准年[2023] | 26.7亿美元 |
预测年份 [2024] | 28.9亿美元 |
预测年份 [2030] | 47.1亿美元 |
复合年增长率(%) | 8.4% |
生物製药製造市场中的病毒检测和定量涵盖涉及生物製药製造流程中病毒污染物识别和测量的技术、服务和解决方案的开发、生产和商业化的行业和部门。增加对生物製药研究和开发的投资正在促进市场成长。在备受瞩目的污染事件后,人们对产品安全的认识不断提高,加上严格的监管要求的出台,正在推动生物製造市场中病毒检测和定量的业务成长。然而,高昂的测试成本和复杂的监管核准流程可能会对中小企业造成进入壁垒,影响市场竞争。此外,需要高技能人员执行和解释复杂的检测也增加了市场空间的操作挑战。此外,新型病毒灭活方法和即时病毒检测技术的开拓将为市场带来创新机会。跨不同平台的检测标准化的研究倡议为市场提供了巨大的成长潜力。
区域洞察
美国和加拿大是生物製造病毒检测和定量的关键市场。这些美洲地区的特点是先进的医疗保健系统、较高的人均医疗费用以及严格的生技药品安全性和有效性法规环境。在欧洲国家,生物製造业不断进步,注重创新、品质和安全。该欧洲、中东和非洲地区的客户热衷于采用符合欧盟严格法规结构的尖端病毒检测技术。由于医疗保健投资增加和生物製药需求不断增长,中东地区呈现出有希望的成长。由于消费者对本地生产和进口生技药品品质保证的需求不断增加,中东地区的病毒检测和定量市场仍处于起步阶段。由于强劲的经济成长、不断增长的医疗支出和不断扩大的技术采用,亚太地区的生物製造领域正在经历快速成长。亚太地区快速成长的疫苗生产产业和出口市场推动了对病毒检测和定量解决方案的需求,客户更喜欢经济高效且可靠的技术。
FPNV定位矩阵
FPNV定位矩阵对于评估生物製造市场中的病毒检测和定量至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对生物製造市场病毒检测和定量供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵考察,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1-市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2-市场开拓:我们深入研究利润丰厚的新兴市场,并分析它们在成熟细分市场中的渗透率。
3- 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4-竞争力评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5- 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1-生物製造中病毒检测和定量市场的市场规模和预测是多少?
2-在生物製造市场病毒检测和定量的预测期内,需要考虑投资哪些产品、细分市场、应用和领域?
3-生物製造中病毒检测和定量市场的技术趋势和法律规范是什么?
4-生物製造市场病毒检测和定量主要厂商的市场占有率是多少?
5-进入生物製造病毒检测和定量市场的适当型态和策略手段是什么?
[194 Pages Report] The Biomanufacturing Viral Detection & Quantification Market size was estimated at USD 2.67 billion in 2023 and expected to reach USD 2.89 billion in 2024, at a CAGR 8.40% to reach USD 4.71 billion by 2030.
Global Biomanufacturing Viral Detection & Quantification Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 2.67 billion |
Estimated Year [2024] | USD 2.89 billion |
Forecast Year [2030] | USD 4.71 billion |
CAGR (%) | 8.4% |
The biomanufacturing viral detection and quantification market encompasses the industries and sectors involved in developing, producing, and commercializing technologies, services, and solutions for identifying and measuring viral contaminants in the biomanufacturing process. The increased investments in biopharmaceutical R&D is contributing to the market growth. The heightened awareness of product safety following high-profile contamination cases and the introduction of stringent regulatory requirements drive the business growth in the biomanufacturing viral detection & quantification market. However, the high costs of testing and the complexity of regulatory approval processes may create barriers to entry for smaller companies, affecting market competitiveness. The need for highly skilled individuals to perform and interpret complex assays adds to market space operational challenges. Moreover, developing novel viral inactivation methods and real-time viral detection technologies creates innovative opportunities in the market. The research initiative, which is directed towards standardizing assays across different platforms, creates significant growth potential in the market.
Regional Insights
In the Americas, the United States and Canada are pivotal markets for biomanufacturing viral detection and quantification. These Americas region is characterized by advanced healthcare systems, high per capita healthcare spending, and stringent regulatory environments that govern the safety and efficacy of biologics. In the European countries, the biomanufacturing sector is advanced with a strong emphasis on innovation, quality, and safety. Customers in this EMEA region are keen on adopting state-of-the-art viral detection technologies that align with the stringent EU regulatory frameworks. The Middle East shows promising growth with increased healthcare investments and a rising demand for biopharmaceuticals. The market for viral detection and quantification in the Middle East region is nascent, with a growing consumer need for quality assurance in locally produced and imported biologics. The Asia Pacific region is experiencing surge in the biomanufacturing domain, due to robust economic growth, increasing healthcare expenditures, and growing technological adoption. The demand for viral detection and quantification solutions is driven by the burgeoning vaccine production sector and export market in the APAC region, with customers showing a preference for cost-effective yet reliable technologies.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Biomanufacturing Viral Detection & Quantification Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biomanufacturing Viral Detection & Quantification Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Biomanufacturing Viral Detection & Quantification Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., BASF SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Charles River Laboratories, Danaher Corporation, Genscript Biotech Corporation, Hamilton Company, Illumina, Inc., LG Chem, Ltd., Lonza Group Ltd., Merck KGaA, New England Biolabs, Norgen Biotek Corp., Oxford Nanopore Technologies PLC, PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Recipharm AB, Sartorius AG, Shimadzu Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Thomas Scientific LLC, and Zymo Research Corporation.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Biomanufacturing Viral Detection & Quantification Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biomanufacturing Viral Detection & Quantification Market?
3. What are the technology trends and regulatory frameworks in the Biomanufacturing Viral Detection & Quantification Market?
4. What is the market share of the leading vendors in the Biomanufacturing Viral Detection & Quantification Market?
5. Which modes and strategic moves are suitable for entering the Biomanufacturing Viral Detection & Quantification Market?